Evidence map›Paper›PMID 32236513›Full record

ArticleThe Journal of cell biology2020

Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint.

Mark Jackman, Chiara Marcozzi, Martina Barbiero, Mercedes Pardo, Lu Yu, Adam L Tyson, Jyoti S Choudhary, Jonathon Pines

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Sustainable integrative cell biology: CENP-C is guilty by association.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mark Jackman *The Institute of Cancer Research, London, UK.
Chiara Marcozzi *The Institute of Cancer Research, London, UK.
Martina BarbieroThe Institute of Cancer Research, London, UK.
Mercedes PardoThe Institute of Cancer Research, London, UK.
Lu YuThe Institute of Cancer Research, London, UK.
Adam L TysonThe Institute of Cancer Research, London, UK.
Jyoti S ChoudharyThe Institute of Cancer Research, London, UK.
Jonathon PinesThe Institute of Cancer Research, London, UK.
Institute of Cancer Research · GB

Funding

Cancer Research UK 24397
6 · The paper itself

Abstract

How the cell rapidly and completely reorganizes its architecture when it divides is a problem that has fascinated researchers for almost 150 yr. We now know that the core regulatory machinery is highly conserved in eukaryotes, but how these multiple protein kinases, protein phosphatases, and ubiquitin ligases are coordinated in space and time to remodel the cell in a matter of minutes remains a major question. Cyclin B1-Cdk is the primary kinase that drives mitotic remodeling; here we show that it is targeted to the nuclear pore complex (NPC) by binding an acidic face of the kinetochore checkpoint protein, MAD1, where it coordinates NPC disassembly with kinetochore assembly. Localized cyclin B1-Cdk1 is needed for the proper release of MAD1 from the embrace of TPR at the nuclear pore so that it can be recruited to kinetochores before nuclear envelope breakdown to maintain genomic stability.

Indexed as

CDC2 Protein KinaseCell Cycle CheckpointsCell Cycle ProteinsCRISPR-Cas SystemsCyclin B1ExonsGene EditingGenomic InstabilityHeLa CellsHumansKinetochoresMad2 ProteinsMass SpectrometryMutationNuclear EnvelopeNuclear PoreCDC2 Protein KinaseCDK1 protein, humanCell Cycle ProteinsCyclin B1MAD1L1 protein, humanMAD2L1 protein, humanMad2 ProteinsNuclear Pore Complex ProteinsNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProto-Oncogene ProteinsTPR protein, humanTTK protein, human

Identifiers

PMID32236513
PMCPMC7265330
OpenAlexW3014300248

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.